Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study - Concepedia

Concepedia

Publication | Open Access

Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study

DOI Full Paper Access

68

Citations

62

References

2021

Year

Stephen J. Nicholls, Steven E. Nissen, Francesco Prati, Stephan Windecker, Yu Kataoka, Rishi Puri, Thomas Hucko, Helina Kassahun, Ransi Somaratne, Julie Butters,

Cardiovascular Diagnosis and Therapy

Abstract

This study was registered on Clinicaltrials.gov (NCT03570697).

References

	Year	Citations

Page 1